The role of non-coding RNAs in chemotherapy for gastrointestinal cancers

Kamb, 2007, Why is cancer drug discovery so difficult?, Nat. Rev. Drug Discov., 6, 115, 10.1038/nrd2155 Lievens, 2017, Global impact of radiotherapy in oncology: Saving one million lives by 2035, Radiother. Oncol., 125, 175, 10.1016/j.radonc.2017.10.027 Wang, 2019, Noncoding RNAs in cancer therapy resistance and targeted drug development, J. Hematol. Oncol., 12, 55, 10.1186/s13045-019-0748-z Guttman, 2012, Modular regulatory principles of large non-coding RNAs, Nature, 482, 339, 10.1038/nature10887 Esteller, 2011, Non-coding RNAs in human disease, Nat. Rev. Genet., 12, 861, 10.1038/nrg3074 Matsui, 2017, Non-coding RNAs as drug targets, Nat. Rev. Drug Discov., 16, 167, 10.1038/nrd.2016.117 Yoon, 2018, Therapeutic potential of small activating RNAs (saRNAs) in human cancers, Curr. Pharm. Biotechnol., 19, 604, 10.2174/1389201019666180528084059 Dong, 2017, Circular RNAs in cancer: An emerging key player, J. Hematol. Oncol., 10, 2, 10.1186/s13045-016-0370-2 Jafarpour, 2018, The radioprotective effects of curcumin and trehalose against genetic damage caused by I-131, Indian J. Nucl. Med., 33, 99, 10.4103/ijnm.IJNM_158_17 Vo, 2019, The landscape of circular RNA in cancer, Cell, 176, 869, 10.1016/j.cell.2018.12.021 Li, 2018, The biogenesis, functions, and challenges of circular RNAs, Mol. Cell, 71, 428, 10.1016/j.molcel.2018.06.034 Yu, 2019, RNA therapy: Are we using the right molecules?, Pharmacol. Ther., 196, 91, 10.1016/j.pharmthera.2018.11.011 Hayes, 2014, MicroRNAs in cancer: biomarkers, functions and therapy, Trends Mol. Med., 20, 460, 10.1016/j.molmed.2014.06.005 Sartorelli, 2020, Enhancer RNAs are an important regulatory layer of the epigenome, Nat. Struct. Mol. Biol., 27, 521, 10.1038/s41594-020-0446-0 Ørom, 2017 Ye, 2020, Enhancer RNA: Biogenesis, function, and regulation, Essays Biochem., 64, 883, 10.1042/EBC20200014 Timmons, 2002, The long and short of siRNAs, Mol. Cell, 10, 435, 10.1016/S1097-2765(02)00657-3 Zhang, 2018, Circular RNAs: A new frontier for cancer diagnosis and therapy, J. Hematol. Oncol., 11, 21, 10.1186/s13045-018-0569-5 Guo, 2018, MicroRNA based prognostic biomarkers in pancreatic cancer, Biomark. Res., 6, 18, 10.1186/s40364-018-0131-1 Fort, 2018, An integrated view of the role of miR-130b/301b miRNA cluster in prostate cancer, Exp. Hematol. Oncol., 7, 10, 10.1186/s40164-018-0102-0 Smolle, 2017, Noncoding RNAs and immune checkpoints-clinical implications as cancer therapeutics, FEBS J., 284, 1952, 10.1111/febs.14030 Bader, 2012, miR-34—A microRNA replacement therapy is headed to the clinic, Front. Genet., 3, 120, 10.3389/fgene.2012.00120 Rupaimoole, 2017, MicroRNA therapeutics: Towards a new era for the management of cancer and other diseases, Nat. Rev. Drug Discov., 16, 203, 10.1038/nrd.2016.246 Liu, 2017, Upregulation of microRNA-135b and microRNA-182 promotes chemoresistance of colorectal cancer by targeting ST6GALNAC2 via PI3K/AKT pathway, Mol. Carcinog., 56, 2669, 10.1002/mc.22710 Xiang, 2015, MicroRNA-135b regulates the stability of PTEN and promotes glycolysis by targeting USP13 in human colorectal cancers, Oncol. Rep., 33, 1342, 10.3892/or.2014.3694 Yang, 2014, Sp1-mediated microRNA-182 expression regulates lung cancer progression, Oncotarget, 5, 740, 10.18632/oncotarget.1608 Wang, 2012, MicroRNA-182 downregulates metastasis suppressor 1 and contributes to metastasis of hepatocellular carcinoma, BMC Cancer, 12, 227, 10.1186/1471-2407-12-227 Gao, 2015, By inhibiting Ras/Raf/ERK and MMP-9, knockdown of EpCAM inhibits breast cancer cell growth and metastasis, Oncotarget, 6, 27187, 10.18632/oncotarget.4551 Yang, 2020, Downregulated LINC01614 ameliorates hypoxia/reoxygenation-stimulated myocardial injury by directly sponging microRNA-138-5p, Dose Response, 18, 10.1177/1559325820913786 Deng, 2019, Exosomes derived from microRNA-138-5p-overexpressing bone marrow-derived mesenchymal stem cells confer neuroprotection to astrocytes following ischemic stroke via inhibition of LCN2, J. Biol. Eng., 13, 71, 10.1186/s13036-019-0193-0 Yu, 2015, MicroRNA-138-5p regulates pancreatic cancer cell growth through targeting FOXC1, Cell Oncol. (Dordr.), 38, 173, 10.1007/s13402-014-0200-x Yu, 2015, Upregulation of microRNA-138-5p inhibits pancreatic cancer cell migration and increases chemotherapy sensitivity, Mol. Med. Rep., 12, 5135, 10.3892/mmr.2015.4031 Gao, 2017, MicroRNA-138-5p controls sensitivity of nasopharyngeal carcinoma to radiation by targeting EIF4EBP1, Oncol. Rep., 37, 913, 10.3892/or.2017.5354 Roberto, 2020, MicroRNA-138-5p as a worse prognosis biomarker in pediatric, adolescent, and young adult osteosarcoma, Pathol. Oncol. Res., 26, 877, 10.1007/s12253-019-00633-0 Zhao, 2019, MicroRNA-138-5p inhibits cell migration, invasion and EMT in breast cancer by directly targeting RHBDD1, Breast Cancer, 26, 817, 10.1007/s12282-019-00989-w Zhu, 2019, miR-138-5p suppresses lung adenocarcinoma cell epithelial-mesenchymal transition, proliferation and metastasis by targeting ZEB2, Pathol. Res. Pract., 215, 861, 10.1016/j.prp.2019.01.029 Xu, 2020, MicroRNA-138-5p targets the NFIB-Snail1 axis to inhibit colorectal cancer cell migration and chemoresistance, Cancer Cell Int., 20, 475, 10.1186/s12935-020-01573-5 Hu, 2010, miR-133b regulates the MET proto-oncogene and inhibits the growth of colorectal cancer cells in vitro and in vivo, Cancer Biol. Ther., 10, 190, 10.4161/cbt.10.2.12186 Wang, 2017, miR-133b suppresses metastasis by targeting HOXA9 in human colorectal cancer, Oncotarget, 8, 63935, 10.18632/oncotarget.19212 Akçakaya, 2011, miR-185 and miR-133b deregulation is associated with overall survival and metastasis in colorectal cancer, Int. J. Oncol., 39, 311 Duan, 2013, miR-133b, a muscle-specific microRNA, is a novel prognostic marker that participates in the progression of human colorectal cancer via regulation of CXCR4 expression, Mol. Cancer, 12, 164, 10.1186/1476-4598-12-164 Lv, 2019, miR-133b suppresses colorectal cancer cell stemness and chemoresistance by targeting methyltransferase DOT1L, Exp. Cell Res., 385, 111597, 10.1016/j.yexcr.2019.111597 Nguyen, 2011, The diverse functions of Dot1 and H3K79 methylation, Genes Dev., 25, 1345, 10.1101/gad.2057811 Yan, 2014, The emerging role of miR-375 in cancer, Int. J. Cancer, 135, 1011, 10.1002/ijc.28563 Zhao, 2018, MicroRNA-655 inhibits cell proliferation and invasion in epithelial ovarian cancer by directly targeting vascular endothelial growth factor, Mol. Med. Rep., 18, 1878 Fan, 2017, miR-375 and doxorubicin co-delivered by liposomes for combination therapy of hepatocellular carcinoma, Mol. Ther. Nucleic Acids, 7, 181, 10.1016/j.omtn.2017.03.010 Wang, 2016, miR-375 induces docetaxel resistance in prostate cancer by targeting SEC23A and YAP1, Mol. Cancer, 15, 70, 10.1186/s12943-016-0556-9 Gaedcke, 2012, The rectal cancer microRNAome—MicroRNA expression in rectal cancer and matched normal mucosa, Clin. Cancer Res., 18, 4919, 10.1158/1078-0432.CCR-12-0016 Conde-Muiño, 2017, Preoperative chemoradiotherapy for rectal cancer: The sensitizer role of the association between miR-375 and c-Myc, Oncotarget, 8, 82294, 10.18632/oncotarget.19393 Mussnich, 2015, miR-199a-5p and miR-375 affect colon cancer cell sensitivity to cetuximab by targeting PHLPP1, Expert Opin. Ther. Targets, 19, 1017, 10.1517/14728222.2015.1057569 Xu, 2019, miR-375-3p suppresses tumorigenesis and partially reverses chemoresistance by targeting YAP1 and SP1 in colorectal cancer cells, Aging (Albany NY), 11, 7357, 10.18632/aging.102214 Kim, 2014, miR-592 and miR-552 can distinguish between primary lung adenocarcinoma and colorectal cancer metastases in the lung, Anticancer Res., 34, 2297 Sarver, 2009, Human colon cancer profiles show differential microRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative states, BMC Cancer, 9, 401, 10.1186/1471-2407-9-401 Qu, 2019, miR-552 promotes the proliferation, migration and EMT of hepatocellular carcinoma cells by inhibiting AJAP1 expression, J. Cell. Mol. Med., 23, 1541, 10.1111/jcmm.14062 Zhao, 2019, MicroRNA-552 deficiency mediates 5-fluorouracil resistance by targeting SMAD2 signaling in DNA-mismatch-repair-deficient colorectal cancer, Cancer Chemother. Pharmacol., 84, 427, 10.1007/s00280-019-03866-7 Feng, 2012, Colorectal cancer migration and invasion initiated by microRNA-106a, PLoS ONE, 7, e43452, 10.1371/journal.pone.0043452 Koga, 2013, Fecal miR-106a is a useful marker for colorectal cancer patients with false-negative results in immunochemical fecal occult blood test, Cancer Epidemiol. Biomarkers Prev., 22, 1844, 10.1158/1055-9965.EPI-13-0512 Liu, 2013, Serum miR-21 and miR-92a as biomarkers in the diagnosis and prognosis of colorectal cancer, Tumour Biol., 34, 2175, 10.1007/s13277-013-0753-8 Díaz, 2008, Deregulated expression of miR-106a predicts survival in human colon cancer patients, Genes Chromosomes Cancer, 47, 794, 10.1002/gcc.20580 Liu, 2020, Overexpression of miR-106a enhances oxaliplatin sensitivity of colorectal cancer through regulation of FOXQ1, Oncol. Lett., 19, 663 Nurul-Syakima, 2011, Differential microRNA expression and identification of putative miRNA targets and pathways in head and neck cancers, Int. J. Mol. Med., 28, 327 Miyamae, 2015, Plasma microRNA profiles: Identification of miR-744 as a novel diagnostic and prognostic biomarker in pancreatic cancer, Br. J. Cancer, 113, 1467, 10.1038/bjc.2015.366 Zhou, 2015, miR-744 increases tumorigenicity of pancreatic cancer by activating Wnt/β-catenin pathway, Oncotarget, 6, 37557, 10.18632/oncotarget.5317 Song, 2012, Identification of serum microRNAs as novel non-invasive biomarkers for early detection of gastric cancer, PLoS ONE, 7, e33608, 10.1371/journal.pone.0033608 Zhou, 2020, miR-744 mediates the oxaliplatin chemoresistance in colorectal cancer through inhibiting BIN1, Neoplasma, 67, 296, 10.4149/neo_2019_190508N411 Sharma, 2015, miR-214: A potential biomarker and therapeutic for different cancers, Future Oncol., 11, 349, 10.2217/fon.14.193 Penna, 2015, miR-214 as a key hub that controls cancer networks: Small player, multiple functions, J. Invest. Dermatol., 135, 960, 10.1038/jid.2014.479 Yang, 2008, MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN, Cancer Res., 68, 425, 10.1158/0008-5472.CAN-07-2488 Long, 2015, MicroRNA-214 functions as a tumor suppressor in human colon cancer via the suppression of ADP-ribosylation factor-like protein 2, Oncol. Lett., 9, 645, 10.3892/ol.2014.2746 Momose, 2013, miR-214 and hypoxia down-regulate Necl-2/CADM1 and enhance ErbB2/ErbB3 signaling, Genes Cells, 18, 195, 10.1111/gtc.12027 Yang, 2019, miR-214 sensitizes human colon cancer cells to 5-FU by targeting Hsp27, Cell. Mol. Biol. Lett., 24, 22, 10.1186/s11658-019-0143-3 Song, 2017, miR-34a sensitizes lung cancer cells to cisplatin via p53/miR-34a/MYCN axis, Biochem. Biophys. Res. Commun., 482, 22, 10.1016/j.bbrc.2016.11.037 Gao, 2015, miR-34a-5p suppresses colorectal cancer metastasis and predicts recurrence in patients with stage II/III colorectal cancer, Oncogene, 34, 4142, 10.1038/onc.2014.348 Wang, 2016, A long non-coding RNA targets microRNA miR-34a to regulate colon cancer stem cell asymmetric division, eLife, 5, e14620, 10.7554/eLife.14620 Lai, 2015, miR-34a inhibits migration and invasion by regulating the SIRT1/p53 pathway in human SW480 cells, Mol. Med. Rep., 11, 3301, 10.3892/mmr.2015.3182 Bu, 2013, A microRNA miR-34a-regulated bimodal switch targets Notch in colon cancer stem cells, Cell Stem Cell, 12, 602, 10.1016/j.stem.2013.03.002 Li, 2015, miR-34a inhibits colon cancer proliferation and metastasis by inhibiting platelet-derived growth factor receptor α, Mol. Med. Rep., 12, 7072, 10.3892/mmr.2015.4263 Li, 2018, miR-34a regulates multidrug resistance via positively modulating OAZ2 signaling in colon cancer cells, J. Immunol. Res., 2018, 7498514 Amankwatia, 2015, MicroRNA-224 is associated with colorectal cancer progression and response to 5-fluorouracil-based chemotherapy by KRAS-dependent and -independent mechanisms, Br. J. Cancer, 112, 1480, 10.1038/bjc.2015.125 Li, 2018, High expression of microRNA-31 and its host gene LOC554202 predict favorable outcomes in patients with colorectal cancer treated with oxaliplatin, Oncol. Rep., 40, 1706 Hu, 2016, The plasma microRNA miR-1914∗ and -1915 suppresses chemoresistant in colorectal cancer patients by down-regulating NFIX, Curr. Mol. Med., 16, 70, 10.2174/1566524016666151222144656 Molina-Pinelo, 2014, miR-107 and miR-99a-3p predict chemotherapy response in patients with advanced colorectal cancer, BMC Cancer, 14, 656, 10.1186/1471-2407-14-656 Gu, 2019, miR-532-3p suppresses colorectal cancer progression by disrupting the ETS1/TGM2 axis-mediated Wnt/β-catenin signaling, Cell Death Dis., 10, 739, 10.1038/s41419-019-1962-x Zhang, 2015, MicroRNA-587 antagonizes 5-FU-induced apoptosis and confers drug resistance by regulating PPP2R1B expression in colorectal cancer, Cell Death Dis., 6, e1845, 10.1038/cddis.2015.200 Fang, 2014, MicroRNA-17-5p promotes chemotherapeutic drug resistance and tumour metastasis of colorectal cancer by repressing PTEN expression, Oncotarget, 5, 2974, 10.18632/oncotarget.1614 Qian, 2013, MicroRNA-143 inhibits tumor growth and angiogenesis and sensitizes chemosensitivity to oxaliplatin in colorectal cancers, Cell Cycle, 12, 1385, 10.4161/cc.24477 Feng, 2018, GDPD5, a target of miR-195-5p, is associated with metastasis and chemoresistance in colorectal cancer, Biomed. Pharmacoth., 101, 945, 10.1016/j.biopha.2018.03.028 Wang, 2017, MicroRNA-93-5p increases multidrug resistance in human colorectal carcinoma cells by downregulating cyclin dependent kinase inhibitor 1A gene expression, Oncol. Lett., 13, 722, 10.3892/ol.2016.5463 Simmer, 2015, MicroRNA-143 is a putative predictive factor for the response to fluoropyrimidine-based chemotherapy in patients with metastatic colorectal cancer, Oncotarget, 6, 22996, 10.18632/oncotarget.4035 Cristóbal, 2017, Downregulation of microRNA-199b predicts unfavorable prognosis and emerges as a novel therapeutic target which contributes to PP2A inhibition in metastatic colorectal cancer, Oncotarget, 8, 40169, 10.18632/oncotarget.11174 Yin, 2014, miR-204-5p inhibits proliferation and invasion and enhances chemotherapeutic sensitivity of colorectal cancer cells by downregulating RAB22A, Clin. Cancer Res., 20, 6187, 10.1158/1078-0432.CCR-14-1030 Xu, 2017, miR-503-5p confers drug resistance by targeting PUMA in colorectal carcinoma, Oncotarget, 8, 21719, 10.18632/oncotarget.15559 Li, 2019, MicroRNA 214 inhibits adipocyte enhancer-binding protein 1 activity and increases the sensitivity of chemotherapy in colorectal cancer, Oncol. Lett., 17, 55 Cao, 2017, MicroRNA-761 promotes the sensitivity of colorectal cancer cells to 5-Fluorouracil through targeting FOXM1, Oncotarget, 9, 321, 10.18632/oncotarget.20109 Wang, 2019, MicroRNA-940 restricts the expression of metastasis-associated gene MACC1 and enhances the antitumor effect of Anlotinib on colorectal cancer, OncoTargets Ther., 12, 2809, 10.2147/OTT.S195364 Xu, 2017, MicroRNA-330 inhibited cell proliferation and enhanced chemosensitivity to 5-fluorouracil in colorectal cancer by directly targeting thymidylate synthase, Oncol. Lett., 13, 3387, 10.3892/ol.2017.5895 Puthanveetil, 2015, Long non-coding RNA MALAT1 regulates hyperglycaemia induced inflammatory process in the endothelial cells, J. Cell. Mol. Med., 19, 1418, 10.1111/jcmm.12576 Sun, 2015, MicroRNA-197 influences 5-fluorouracil resistance via thymidylate synthase in colorectal cancer, Clin. Trans. Oncol., 17, 876, 10.1007/s12094-015-1318-7 Zhang, 2015, MicroRNA-520g confers drug resistance by regulating p21 expression in colorectal cancer, J. Biol. Chem., 290, 6215, 10.1074/jbc.M114.620252 Wang, 2013, PEG2000-DPSE-coated quercetin nanoparticles remarkably enhanced anticancer effects through induced programed cell death on C6 glioma cells, J. Biomed. Mater. Res. A, 101, 3076, 10.1002/jbm.a.34607 Sui, 2014, miR200c attenuates P-gp-mediated MDR and metastasis by targeting JNK2/c-Jun signaling pathway in colorectal cancer, Mol. Cancer Ther., 13, 3137, 10.1158/1535-7163.MCT-14-0167 Zhang, 2018, Knockdown of miR-20a enhances sensitivity of colorectal cancer cells to cisplatin by increasing ASK1 expression, Cell. Physiol. Biochem., 47, 1432, 10.1159/000490834 Liu, 2016, MicroRNA-149 increases the sensitivity of colorectal cancer cells to 5-fluorouracil by targeting forkhead box transcription factor FOXM1, Cell. Physiol. Biochem., 39, 617, 10.1159/000445653 Yao, 2019, miR-1271 enhances the sensitivity of colorectal cancer cells to cisplatin, Exp. Ther. Med., 17, 4363 Borralho, 2009, MicroRNA-143 reduces viability and increases sensitivity to 5-fluorouracil in HCT116 human colorectal cancer cells, FEBS J., 276, 6689, 10.1111/j.1742-4658.2009.07383.x Chen, 2017, Upregulation of miR-199a/b contributes to cisplatin resistance via Wnt/β-catenin-ABCG2 signaling pathway in ALDHA1+ colorectal cancer stem cells, Tumour Biol., 39, 10.1177/1010428317715155 Karaayvaz, 2013, miR-129 promotes apoptosis and enhances chemosensitivity to 5-fluorouracil in colorectal cancer, Cell Death Dis., 4, e659, 10.1038/cddis.2013.193 Liu, 2011, Increased expression of microRNA-21and its association with chemotherapeutic response in human colorectal cancer, J. Int. Med. Res., 39, 2288 Qin, 2018, miR-106a reduces 5-fluorouracil (5-FU) sensitivity of colorectal cancer by targeting dual-specificity phosphatases 2 (DUSP2), Med. Sci. Monit., 24, 4944, 10.12659/MSM.910016 Zhang, 2019, miR-361 enhances sensitivity to 5-fluorouracil by targeting the FOXM1-ABCC5/10 signaling pathway in colorectal cancer, Oncol. Lett., 18, 4064 Liu, 2016, miR-139-5p sensitizes colorectal cancer cells to 5-fluorouracil by targeting NOTCH-1, Pathol. Res. Pract., 212, 643, 10.1016/j.prp.2016.04.011 Kim, 2018, MicroRNA-195 desensitizes HCT116 human colon cancer cells to 5-fluorouracil, Cancer Lett., 412, 264, 10.1016/j.canlet.2017.10.022 Liu, 2015, miRNA-497 enhances the sensitivity of colorectal cancer cells to neoadjuvant chemotherapeutic drug, Curr. Protein Pept. Sci., 16, 310, 10.2174/138920371604150429154142 To, 2015, Exploiting a novel miR-519c-HuR-ABCG2 regulatory pathway to overcome chemoresistance in colorectal cancer, Exp. Cell Res., 338, 222, 10.1016/j.yexcr.2015.09.011 Liu, 2019, Down-regulation of miR-543 expression increases the sensitivity of colorectal cancer cells to 5-fluorouracil through the PTEN/PI3K/AKT pathway, Biosci. Rep., 39 Sun, 2017, miR-34a mediates oxaliplatin resistance of colorectal cancer cells by inhibiting macroautophagy via transforming growth factor-β/Smad4 pathway, World J. Gastroenterol., 23, 1816, 10.3748/wjg.v23.i10.1816 Hansen, 2012, The predictive value of microRNA-126 in relation to first line treatment with capecitabine and oxaliplatin in patients with metastatic colorectal cancer, BMC Cancer, 12, 83, 10.1186/1471-2407-12-83 Ye, 2017, miR-1290 is a biomarker in DNA-mismatch-repair-deficient colon cancer and promotes resistance to 5-fluorouracil by directly targeting hMSH2, Mol. Ther. Nucleic Acids, 7, 453, 10.1016/j.omtn.2017.05.006 Zhang, 2020, miR-770-5p modulates resistance to methotrexate in human colorectal adenocarcinoma cells by downregulating HIPK1, Exp. Ther. Med., 19, 339 Heydari, 2018, The effect of mir-200c inhibition on chemosensitivity (5-fluorouracil) in colorectal cancer, Pathol. Oncol. Res., 24, 145, 10.1007/s12253-017-0222-6 Chai, 2011, miR-20a targets BNIP2 and contributes chemotherapeutic resistance in colorectal adenocarcinoma SW480 and SW620 cell lines, Acta Biochim. Biophys. Sin. (Shanghai), 43, 217, 10.1093/abbs/gmq125 Chen, 2017, Upregulation of miR-101 enhances the cytotoxic effect of anticancer drugs through inhibition of colon cancer cell proliferation, Oncol. Rep., 38, 100, 10.3892/or.2017.5666 Liu, 2016, Overexpression of miR-203 sensitizes paclitaxel (Taxol)-resistant colorectal cancer cells through targeting the salt-inducible kinase 2 (SIK2), Tumour Biol., 37, 12231, 10.1007/s13277-016-5066-2 Ren, 2017, Maintenance of cancer stemness by miR-196b-5p contributes to chemoresistance of colorectal cancer cells via activating STAT3 signaling pathway, Oncotarget, 8, 49807, 10.18632/oncotarget.17971 Tan, 2016, miR-409-3p sensitizes colon cancer cells to oxaliplatin by inhibiting Beclin-1-mediated autophagy, Int. J. Mol. Med., 37, 1030, 10.3892/ijmm.2016.2492 Han, 2017, miR-338-3p confers 5-fluorouracil resistance in p53 mutant colon cancer cells by targeting the mammalian target of rapamycin, Exp. Cell Res., 360, 328, 10.1016/j.yexcr.2017.09.023 Liang, 2020, miR-107 confers chemoresistance to colorectal cancer by targeting calcium-binding protein 39, Br. J. Cancer, 122, 705, 10.1038/s41416-019-0703-3 Pranzini, 2019, miR-210-3p mediates metabolic adaptation and sustains DNA damage repair of resistant colon cancer cells to treatment with 5-fluorouracil, Mol. Carcinog., 58, 2181, 10.1002/mc.23107 Liu, 2015, Tumor suppressor miR-145 reverses drug resistance by directly targeting DNA damage-related gene RAD18 in colorectal cancer, Tumour Biol., 36, 5011, 10.1007/s13277-015-3152-5 Que, 2017, Downregulation of miR-874-3p promotes chemotherapeutic resistance in colorectal cancer via inactivation of the Hippo signaling pathway, Oncol. Rep., 38, 3376 Li, 2015, Inhibition of lactate dehydrogenase A by microRNA-34a resensitizes colon cancer cells to 5-fluorouracil, Mol. Med. Rep., 11, 577, 10.3892/mmr.2014.2726 Zhou, 2014, miR-203 induces oxaliplatin resistance in colorectal cancer cells by negatively regulating ATM kinase, Mol. Oncol., 8, 83, 10.1016/j.molonc.2013.09.004 Peng, 2015, miR-492 is functionally involved in oxaliplatin resistance in colon cancer cells LS174T via its regulating the expression of CD147, Mol. Cell. Biochem., 405, 73, 10.1007/s11010-015-2397-z Deng, 2014, Targeting miR-21 enhances the sensitivity of human colon cancer HT-29 cells to chemoradiotherapy in vitro, Biochem. Biophys. Res. Commun., 443, 789, 10.1016/j.bbrc.2013.11.064 Xu, 2012, miR-222 modulates multidrug resistance in human colorectal carcinoma by down-regulating ADAM-17, Exp. Cell Res., 318, 2168, 10.1016/j.yexcr.2012.04.014 Tu, 2016, MicroRNA-1291 targets the FOXA2-AGR2 pathway to suppress pancreatic cancer cell proliferation and tumorigenesis, Oncotarget, 7, 45547, 10.18632/oncotarget.9999 Bi, 2014, N-methylnicotinamide and nicotinamide N-methyltransferase are associated with microRNA-1291-altered pancreatic carcinoma cell metabolome and suppressed tumorigenesis, Carcinogenesis, 35, 2264, 10.1093/carcin/bgu174 Yamasaki, 2013, Tumor-suppressive microRNA-1291 directly regulates glucose transporter 1 in renal cell carcinoma, Cancer Sci., 104, 1411, 10.1111/cas.12240 Tu, 2020, MicroRNA-1291-5p sensitizes pancreatic carcinoma cells to arginine deprivation and chemotherapy through the regulation of arginolysis and glycolysis, Mol. Pharmacol., 98, 686, 10.1124/molpharm.120.000130 Zhang, 2019, Histone deacetylase inhibitors sensitize TRAIL-induced apoptosis in colon cancer cells, Cancers (Basel), 11, 645, 10.3390/cancers11050645 Eberle, 2019, Countering trail resistance in melanoma, Cancers (Basel), 11, 656, 10.3390/cancers11050656 Hopkins-Donaldson, 2000, Loss of caspase-8 expression in highly malignant human neuroblastoma cells correlates with resistance to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis, Cancer Res., 60, 4315 Yang, 2003, Induction of caspase 8 by interferon γ renders some neuroblastoma (NB) cells sensitive to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) but reveals that a lack of membrane TR1/TR2 also contributes to TRAIL resistance in NB, Cancer Res., 63, 1122 Xia, 2017, Downregulation of miR-301a-3p sensitizes pancreatic cancer cells to gemcitabine treatment via PTEN, Am. J. Transl. Res., 9, 1886 Lu, 2011, miR-301a as an NF-κB activator in pancreatic cancer cells, EMBO J., 30, 57, 10.1038/emboj.2010.296 Moeng, 2020, Luteolin-regulated microRNA-301-3p targets caspase-8 and modulates TRAIL sensitivity in PANC-1 cells, Anticancer Res., 40, 723, 10.21873/anticanres.14003 Li, 2017, miR-137 acts as a tumor suppressor via inhibiting CXCL12 in human glioblastoma, Oncotarget, 8, 101262, 10.18632/oncotarget.20589 Shen, 2016, MicroRNA-137 inhibits tumor growth and sensitizes chemosensitivity to paclitaxel and cisplatin in lung cancer, Oncotarget, 7, 20728, 10.18632/oncotarget.8011 Takwi, 2014, miR-137 regulates the constitutive androstane receptor and modulates doxorubicin sensitivity in parental and doxorubicin-resistant neuroblastoma cells, Oncogene, 33, 3717, 10.1038/onc.2013.330 Li, 2014, MicroRNA-137 is a novel hypoxia-responsive microRNA that inhibits mitophagy via regulation of two mitophagy receptors FUNDC1 and NIX, J. Biol. Chem., 289, 10691, 10.1074/jbc.M113.537050 Zeng, 2015, MIR137 regulates starvation-induced autophagy by targeting ATG7, J. Mol. Neurosci., 56, 815, 10.1007/s12031-015-0514-9 Neault, 2016, miR-137 modulates a tumor suppressor network-inducing senescence in pancreatic cancer cells, Cell Rep., 14, 1966, 10.1016/j.celrep.2016.01.068 Xiao, 2014, MicroRNA-137 modulates pancreatic cancer cells tumor growth, invasion and sensitivity to chemotherapy, Int. J. Clin. Exp. Pathol., 7, 7442 Wang, 2019, MicroRNA-137 inhibits autophagy and chemosensitizes pancreatic cancer cells by targeting ATG5, Int. J. Biochem. Cell Biol., 111, 63, 10.1016/j.biocel.2019.01.020 Smith, 2010, Glucocorticoids modulate microRNA expression and processing during lymphocyte apoptosis, J. Biol. Chem., 285, 36698, 10.1074/jbc.M110.162123 Herr, 2003, Glucocorticoid cotreatment induces apoptosis resistance toward cancer therapy in carcinomas, Cancer Res., 63, 3112 Qin, 2015, Downregulation of microRNA-132 by DNA hypermethylation is associated with cell invasion in colorectal cancer, OncoTargets Ther., 8, 3639 Abukiwan, 2019, Dexamethasone-induced inhibition of miR-132 via methylation promotes TGF-β-driven progression of pancreatic cancer, Int. J. Oncol., 54, 53 Jones, 2017, miRNA signatures of insulin resistance in obesity, Obesity (Silver Spring), 25, 1734, 10.1002/oby.21950 Xu, 2017, Differential expression of microRNAs in calcific aortic stenosis, Clin. Lab., 63, 1163, 10.7754/Clin.Lab.2017.170108 Tan, 2017, MicroRNAs regulating cluster of differentiation 46 (CD46) in cardioembolic and non-cardioembolic stroke, PLoS ONE, 12, e0172131, 10.1371/journal.pone.0172131 Hu, 2015, Increased miR-374b promotes cell proliferation and the production of aberrant glycosylated IgA1 in B cells of IgA nephropathy, FEBS Lett., 589, 4019, 10.1016/j.febslet.2015.10.033 Wang, 2011, Altered profile of seminal plasma microRNAs in the molecular diagnosis of male infertility, Clin. Chem., 57, 1722, 10.1373/clinchem.2011.169714 Zhang, 2017, Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling, Gene, 619, 10, 10.1016/j.gene.2017.03.038 Chang, 2016, Identification of MicroRNAs as breast cancer prognosis markers through the cancer genome atlas, PLoS ONE, 11, e0168284, 10.1371/journal.pone.0168284 Hanniford, 2015, A miRNA-based signature detected in primary melanoma tissue predicts development of brain metastasis, Clin. Cancer Res., 21, 4903, 10.1158/1078-0432.CCR-14-2566 Summerer, 2015, Circulating microRNAs as prognostic therapy biomarkers in head and neck cancer patients, Br. J. Cancer, 113, 76, 10.1038/bjc.2015.111 Xie, 2014, miR-374b-5p suppresses RECK expression and promotes gastric cancer cell invasion and metastasis, World J. Gastroenterol., 20, 17439, 10.3748/wjg.v20.i46.17439 He, 2013, Global analysis of the differentially expressed miRNAs of prostate cancer in Chinese patients, BMC Genomics, 14, 757, 10.1186/1471-2164-14-757 Qian, 2015, MicroRNA-374b suppresses proliferation and promotes apoptosis in T-cell lymphoblastic lymphoma by repressing AKT1 and Wnt-16, Clin. Cancer Res., 21, 4881, 10.1158/1078-0432.CCR-14-2947 Wu, 2015, The potential value of miR-1 and miR-374b as biomarkers for colorectal cancer, Int. J. Clin. Exp. Pathol., 8, 2840 Schreiber, 2016, Evidence for the role of microRNA 374b in acquired cisplatin resistance in pancreatic cancer cells, Cancer Gene Ther., 23, 241, 10.1038/cgt.2016.23 Sun, 2018, Downregulation of miR-374b-5p promotes chemotherapeutic resistance in pancreatic cancer by upregulating multiple anti-apoptotic proteins, Int. J. Oncol., 52, 1491 Tu, 2020, MicroRNA-1291-5p sensitizes pancreatic carcinoma cells to arginine deprivation and chemotherapy through the regulation of arginolysis and glycolysis, Mol. Pharmacol., 98, 686, 10.1124/molpharm.120.000130 Li, 2014, MicroRNA-100 regulates pancreatic cancer cells growth and sensitivity to chemotherapy through targeting FGFR3, Tumour Biol., 35, 11751, 10.1007/s13277-014-2271-8 Sheu-Gruttadauria, 2019, Structural basis for target-directed microrna degradation, Mol. Cell, 75, 1243, 10.1016/j.molcel.2019.06.019 Ying, 2018, Identification of eight key miRNAs associated with renal cell carcinoma: a meta-analysis, Oncol Lett, 16, 5847 Toste, 2015, p85α is a microRNA target and affects chemosensitivity in pancreatic cancer, J. Surg. Res., 196, 285, 10.1016/j.jss.2015.02.071 Wei, 2016, MicroRNA-21 induces 5-fluorouracil resistance in human pancreatic cancer cells by regulating PTEN and PDCD4, Cancer Med., 5, 693, 10.1002/cam4.626 Yu, 2017, MicroRNA-429 sensitizes pancreatic cancer cells to gemcitabine through regulation of PDCD4, Am. J. Transl. Res., 9, 5048 Wang, 2019, miR-30a regulates cancer cell response to chemotherapy through SNAI1/IRS1/AKT pathway, Cell Death Dis., 10, 153, 10.1038/s41419-019-1326-6 Zhao, 2016, miRNA-221-3p desensitizes pancreatic cancer cells to 5-fluorouracil by targeting RB1, Tumour Biol., 37, 16053, 10.1007/s13277-016-5445-8 Wang, 2016, MicroRNA-320a promotes 5-FU resistance in human pancreatic cancer cells, Sci. Rep., 6, 27641, 10.1038/srep27641 Wang, 2013, The serum miR-21 level serves as a predictor for the chemosensitivity of advanced pancreatic cancer, and miR-21 expression confers chemoresistance by targeting FasL, Mol. Oncol., 7, 334, 10.1016/j.molonc.2012.10.011 Huang, 2017, MicroRNA-1285 inhibits malignant biological behaviors of human pancreatic cancer cells by negative regulation of YAP1, Neoplasma, 64, 358, 10.4149/neo_2017_306 Yang, 2017, miR-3656 expression enhances the chemosensitivity of pancreatic cancer to gemcitabine through modulation of the RHOF/EMT axis, Cell Death Dis., 8, e3129, 10.1038/cddis.2017.530 Xu, 2019, A-to-I-edited miRNA-379-5p inhibits cancer cell proliferation through CD97-induced apoptosis, J. Clin. Invest., 129, 5343, 10.1172/JCI123396 Iwagami, 2013, miR-320c regulates gemcitabine-resistance in pancreatic cancer via SMARCC1, Br. J. Cancer, 109, 502, 10.1038/bjc.2013.320 Maftouh, 2014, miR-211 modulates gemcitabine activity through downregulation of ribonucleotide reductase and inhibits the invasive behavior of pancreatic cancer cells, Nucleosides Nucleotides Nucleic Acids, 33, 384, 10.1080/15257770.2014.891741 Fan, 2016, MicroRNA-101-3p reverses gemcitabine resistance by inhibition of ribonucleotide reductase M1 in pancreatic cancer, Cancer Lett., 373, 130, 10.1016/j.canlet.2016.01.038 Xiong, 2017, MicroRNA-410-3p attenuates gemcitabine resistance in pancreatic ductal adenocarcinoma by inhibiting HMGB1-mediated autophagy, Oncotarget, 8, 107500, 10.18632/oncotarget.22494 Paik, 2013, Chemosensitivity induced by down-regulation of microRNA-21 in gemcitabine-resistant pancreatic cancer cells by indole-3-carbinol, Anticancer Res., 33, 1473 Zheng, 2020, Upregulation of miR-34c after silencing E2F transcription factor 1 inhibits paclitaxel combined with cisplatin resistance in gastric cancer cells, World J. Gastroenterol., 26, 499, 10.3748/wjg.v26.i5.499 Liu, 2018, MicroRNA-567 inhibits cell proliferation, migration and invasion by targeting FGF5 in osteosarcoma, EXCLI J., 17, 102 Shao, 2017, Diagnostic microRNA biomarker discovery for non-small-cell lung cancer adenocarcinoma by integrative bioinformatics analysis, BioMed Res. Int., 2017, 2563085, 10.1155/2017/2563085 Wang, 2014, Multiple regression analysis of mRNA-miRNA associations in colorectal cancer pathway, BioMed Res. Int., 2014, 676724 Cava, 2014, Integration of mRNA expression profile, copy number alterations, and microRNA expression levels in breast cancer to improve grade definition, PLoS ONE, 9, e97681, 10.1371/journal.pone.0097681 Bertoli, 2017, MicroRNA-567 dysregulation contributes to carcinogenesis of breast cancer, targeting tumor cell proliferation, and migration, Breast Cancer Res. Treat., 161, 605, 10.1007/s10549-016-4079-2 Zhang, 2019, A miR-567-PIK3AP1-PI3K/AKT-c-Myc feedback loop regulates tumour growth and chemoresistance in gastric cancer, EBioMedicine, 44, 311, 10.1016/j.ebiom.2019.05.003 Liang, 2018, A novel long non-coding RNA-PRLB acts as a tumor promoter through regulating miR-4766-5p/SIRT1 axis in breast cancer, Cell Death Dis., 9, 563, 10.1038/s41419-018-0582-1 Pajerowski, 2009, NKAP is a transcriptional repressor of notch signaling and is required for T cell development, Immunity, 30, 696, 10.1016/j.immuni.2009.02.011 Hsu, 2011, NKAP is required for T cell maturation and acquisition of functional competency, J. Exp. Med., 208, 1291, 10.1084/jem.20101874 Juan, 2010 Burgute, 2014, NKAP is a novel RS-related protein that interacts with RNA and RNA binding proteins, Nucleic Acids Res., 42, 3177, 10.1093/nar/gkt1311 Li, 2016, SUMOylated NKAP is essential for chromosome alignment by anchoring CENP-E to kinetochores, Nat. Commun., 7, 12969, 10.1038/ncomms12969 Wei, 2019, miR-4766-5p inhibits the development and progression of gastric cancer by targeting NKAP, OncoTargets Ther., 12, 8525, 10.2147/OTT.S220234 Wang, 2013, Decreased expression of microRNA-31 associates with aggressive tumor progression and poor prognosis in patients with bladder cancer, Clin. Transl. Oncol., 15, 849, 10.1007/s12094-013-1014-4 Wang, 2010, Suppression of microRNA-31 increases sensitivity to 5-FU at an early stage, and affects cell migration and invasion in HCT-116 colon cancer cells, BMC Cancer, 10, 616, 10.1186/1471-2407-10-616 Wang, 2016, Downregulated miR-31 level associates with poor prognosis of gastric cancer and its restoration suppresses tumor cell malignant phenotypes by inhibiting E2F2, Oncotarget, 7, 36577, 10.18632/oncotarget.9288 Zhang, 2010, Down-regulation of miR-31 expression in gastric cancer tissues and its clinical significance, Med. Oncol., 27, 685, 10.1007/s12032-009-9269-x Au, 2012, Enhancer of zeste homolog 2 epigenetically silences multiple tumor suppressor microRNAs to promote liver cancer metastasis, Hepatology, 56, 622, 10.1002/hep.25679 Saramäki, 2006, The gene for polycomb group protein enhancer of zeste homolog 2 (EZH2) is amplified in late-stage prostate cancer, Genes Chromosomes Cancer, 45, 639, 10.1002/gcc.20327 Mimori, 2005, Clinical significance of enhancer of zeste homolog 2 expression in colorectal cancer cases, Eur. J. Surg. Oncol., 31, 376, 10.1016/j.ejso.2004.11.001 Sun, 2019, MicroRNA-31 triggers G2/M cell cycle arrest, enhances the chemosensitivity and inhibits migration and invasion of human gastric cancer cells by downregulating the expression of zeste homolog 2 (ZH2), Arch. Biochem. Biophys., 663, 269, 10.1016/j.abb.2019.01.023 Feng, 2014, miR-200, a new star miRNA in human cancer, Cancer Lett., 344, 166, 10.1016/j.canlet.2013.11.004 Liu, 2018, Effects of miR-200a and FH535 combined with taxol on proliferation and invasion of gastric cancer, Pathol. Res. Pract., 214, 442, 10.1016/j.prp.2017.12.004 Chang, 2014, MicroRNA-200c regulates the sensitivity of chemotherapy of gastric cancer SGC7901/DDP cells by directly targeting RhoE, Pathol. Oncol. Res., 20, 93, 10.1007/s12253-013-9664-7 Jiang, 2017, MicroRNA-200c regulates cisplatin resistance by targeting ZEB2 in human gastric cancer cells, Oncol. Rep., 38, 151, 10.3892/or.2017.5659 Zhang, 2017, MicroRNA-200c binding to FN1 suppresses the proliferation, migration and invasion of gastric cancer cells, Biomed. Pharmacother., 88, 285, 10.1016/j.biopha.2017.01.023 Liu, 2017, miR-200c regulates tumor growth and chemosensitivity to cisplatin in osteosarcoma by targeting AKT2, Sci. Rep., 7, 13598, 10.1038/s41598-017-14088-3 Ghasabi, 2019, The effect of combined miR-200c replacement and cisplatin on apoptosis induction and inhibition of gastric cancer cell line migration, J. Cell. Physiol., 234, 22581, 10.1002/jcp.28823 Ni, 2015, MicroRNA-362-5p promotes tumor growth and metastasis by targeting CYLD in hepatocellular carcinoma, Cancer Lett., 356, 809, 10.1016/j.canlet.2014.10.041 Wei, 2019, MicroRNA-362-5p enhances the cisplatin sensitivity of gastric cancer cells by targeting suppressor of zeste 12 protein, Oncol. Lett., 18, 1607 Wang, 2018, Exosomes serve as nanoparticles to deliver anti-miR-214 to reverse chemoresistance to cisplatin in gastric cancer, Mol. Ther., 26, 774, 10.1016/j.ymthe.2018.01.001 Korourian, 2017, MicroRNA-31 inhibits RhoA-mediated tumor invasion and chemotherapy resistance in MKN-45 gastric adenocarcinoma cells, Exp. Biol. Med. (Maywood), 242, 1842, 10.1177/1535370217728460 Zhang, 2017, The functional mechanism of miR-125b in gastric cancer and its effect on the chemosensitivity of cisplatin, Oncotarget, 9, 2105, 10.18632/oncotarget.23249 Sacconi, 2012, miR-204 targets Bcl-2 expression and enhances responsiveness of gastric cancer, Cell Death Dis., 3, e423, 10.1038/cddis.2012.160 Li, 2018, Sensitization of gastric cancer cells to 5-FU by microRNA-204 through targeting the TGFBR2-mediated epithelial to mesenchymal transition, Cell. Physiol. Biochem., 47, 1533, 10.1159/000490871 Guo, 2019, PCAT-1 contributes to cisplatin resistance in gastric cancer through miR-128/ZEB1 axis, Biomed. Pharmacother., 118, 109255, 10.1016/j.biopha.2019.109255 Cao, 2018, Regulation of drug resistance and metastasis of gastric cancer cells via the microRNA647-ANK2 axis, Int. J. Mol. Med., 41, 1958 Wang, 2015, Chemotherapy-induced miRNA-29c/catenin-δ signaling suppresses metastasis in gastric cancer, Cancer Res., 75, 1332, 10.1158/0008-5472.CAN-14-0787 Zhou, 2018, miR-200c inhibits TGF-β-induced-EMT to restore trastuzumab sensitivity by targeting ZEB1 and ZEB2 in gastric cancer, Cancer Gene Ther., 25, 68, 10.1038/s41417-017-0005-y Han, 2018, Let-7b attenuates cisplatin resistance and tumor growth in gastric cancer by targeting AURKB, Cancer Gene Ther., 25, 300, 10.1038/s41417-018-0048-8 Yan, 2016, miR-135a promotes gastric cancer progression and resistance to oxaliplatin, Oncotarget, 7, 70699, 10.18632/oncotarget.12208 Zhao, 2016, miR-181a suppresses autophagy and sensitizes gastric cancer cells to cisplatin, Gene, 576, 828, 10.1016/j.gene.2015.11.013 Chen, 2018, miR-21-5p confers doxorubicin resistance in gastric cancer cells by targeting PTEN and TIMP3, Int. J. Mol. Med., 41, 1855 Wen, 2015, miR-26a enhances the sensitivity of gastric cancer cells to cisplatin by targeting NRAS and E2F2, Saudi J. Gastroenterol., 21, 313, 10.4103/1319-3767.166206 Pang, 2020, miR-15a-5p targets PHLPP2 in gastric cancer cells to modulate platinum resistance and is a suitable serum biomarker for oxaliplatin resistance, Neoplasma, 67, 1114, 10.4149/neo_2020_190904N861 Wang, 2017, Upregulation of microRNA-524-5p enhances the cisplatin sensitivity of gastric cancer cells by modulating proliferation and metastasis via targeting SOX9, Oncotarget, 8, 574, 10.18632/oncotarget.13479 Zhang, 2016, Upregulation of microRNA-34a enhances the DDP sensitivity of gastric cancer cells by modulating proliferation and apoptosis via targeting MET, Oncol. Rep., 36, 2391, 10.3892/or.2016.5016 Zhang, 2018, MicroRNA-218 enhances gastric cancer cell cisplatin sensitivity by targeting survivin, Exp. Ther. Med., 16, 4796 Zhou, 2016, Upregulation of microRNA-375 increases the cisplatin-sensitivity of human gastric cancer cells by regulating ERBB2, Exp. Ther. Med., 11, 625, 10.3892/etm.2015.2920 Wang, 2016, MicroRNA-126 increases chemosensitivity in drug-resistant gastric cancer cells by targeting EZH2, Biochem. Biophys. Res. Commun., 479, 91, 10.1016/j.bbrc.2016.09.040 Li, 2018, MicroRNA-495 confers increased sensitivity to chemotherapeutic agents in gastric cancer via the mammalian target of rapamycin (mTOR) signaling pathway by interacting with human epidermal growth factor receptor 2 (ERBB2), Med. Sci. Monit., 24, 5960, 10.12659/MSM.909458 Pires, 2016, Unveiling the differences of secretome of human bone marrow mesenchymal stem cells, adipose tissue-derived stem cells, and human umbilical cord perivascular cells: a proteomic analysis, Stem Cells Dev., 25, 1073, 10.1089/scd.2016.0048 Li, 2014, MicroRNA-185 regulates chemotherapeutic sensitivity in gastric cancer by targeting apoptosis repressor with caspase recruitment domain, Cell Death Dis., 5, e1197, 10.1038/cddis.2014.148 Zhu, 2015, miR-429 induces gastric carcinoma cell apoptosis through Bcl-2, Cell. Physiol. Biochem., 37, 1572, 10.1159/000438524 Zhu, 2016, miR-20a induces cisplatin resistance of a human gastric cancer cell line via targeting CYLD, Mol. Med. Rep., 14, 1742, 10.3892/mmr.2016.5413 Zhao, 2018, miR-16-1 targeted silences far upstream element binding protein 1 to advance the chemosensitivity to adriamycin in gastric cancer, Pathol. Oncol. Res., 24, 483, 10.1007/s12253-017-0263-x Yang, 2013, miR-21 confers cisplatin resistance in gastric cancer cells by regulating PTEN, Toxicology, 306, 162, 10.1016/j.tox.2013.02.014 Zhou, 2015, miR-223 promotes the cisplatin resistance of human gastric cancer cells via regulating cell cycle by targeting FBXW7, J. Exp. Clin. Cancer Res., 34, 28, 10.1186/s13046-015-0145-6 Lu, 2017, miR-129 regulates cisplatin-resistance in human gastric cancer cells by targeting P-gp, Biomed. Pharmacother., 86, 450, 10.1016/j.biopha.2016.11.139 Eto, 2014, The microRNA-21/PTEN pathway regulates the sensitivity of HER2-positive gastric cancer cells to trastuzumab, Ann. Surg. Oncol., 21, 343, 10.1245/s10434-013-3325-7 Qian, 2020, MicroRNA-4290 suppresses PDK1-mediated glycolysis to enhance the sensitivity of gastric cancer cell to cisplatin, Braz. J. Med. Biol. Res., 53, e9330, 10.1590/1414-431x20209330 Guan, 2015, Down-regulation of miR-144 promotes thyroid cancer cell invasion by targeting ZEB1 and ZEB2, Endocrine, 48, 566, 10.1007/s12020-014-0326-7 Zha, 2013, Roles of Mir-144-ZFX pathway in growth regulation of non-small-cell lung cancer, PLoS ONE, 8, e74175, 10.1371/journal.pone.0074175 Huang, 2015, MicroRNA-486-5p, which is downregulated in hepatocellular carcinoma, suppresses tumor growth by targeting PIK3R1, FEBS J., 282, 579, 10.1111/febs.13167 Bruhn, 2013, AKT-independent PI3-K signaling in cancer—Emerging role for SGK3, Cancer Manag. Res., 5, 281 Cao, 2014, miR-144 suppresses the proliferation and metastasis of hepatocellular carcinoma by targeting E2F3, Tumour Biol., 35, 10759, 10.1007/s13277-014-2017-7 Wang, 2013, MicroRNA-195 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting the expression of VEGF, VAV2, and CDC42, Hepatology, 58, 642, 10.1002/hep.26373 Yang, 2014, MicroRNA-26a suppresses angiogenesis in human hepatocellular carcinoma by targeting hepatocyte growth factor-cMet pathway, Hepatology, 59, 1874, 10.1002/hep.26941 Wu, 2017, MicroRNA-144-3p suppresses tumor growth and angiogenesis by targeting SGK3 in hepatocellular carcinoma, Oncol. Rep., 38, 2173, 10.3892/or.2017.5900 Agarwal, 2015, Predicting effective microRNA target sites in mammalian mRNAs, Elife, 4, e05005, 10.7554/eLife.05005 Kutay, 2006, Downregulation of miR-122 in the rodent and human hepatocellular carcinomas, J. Cell. Biochem., 99, 671, 10.1002/jcb.20982 Xu, 2011, MicroRNA-122 sensitizes HCC cancer cells to adriamycin and vincristine through modulating expression of MDR and inducing cell cycle arrest, Cancer Lett., 310, 160 Fornari, 2009, miR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells, Cancer Res., 69, 5761, 10.1158/0008-5472.CAN-08-4797 Coulouarn, 2009, Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties, Oncogene, 28, 3526, 10.1038/onc.2009.211 Tsai, 2009, MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma, Hepatology, 49, 1571, 10.1002/hep.22806 Ma, 2010, Expression of miR-122 mediated by adenoviral vector induces apoptosis and cell cycle arrest of cancer cells, Cancer Biol. Ther., 9, 554, 10.4161/cbt.9.7.11267 Bandiera, 2015, miR-122—A key factor and therapeutic target in liver disease, J. Hepatol., 62, 448, 10.1016/j.jhep.2014.10.004 Morita, 2011, Clinical significance and potential of hepatic microRNA-122 expression in hepatitis C, Liver Int., 31, 474, 10.1111/j.1478-3231.2010.02433.x Bai, 2009, MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib, J. Biol. Chem., 284, 32015, 10.1074/jbc.M109.016774 Xu, 2012, MicroRNA-122 suppresses cell proliferation and induces cell apoptosis in hepatocellular carcinoma by directly targeting Wnt/β-catenin pathway, Liver Int., 32, 752, 10.1111/j.1478-3231.2011.02750.x Grainger, 2018, Mechanisms of Wnt signaling and control, Wiley Interdiscip. Rev. Syst. Biol. Med., 10, e1422, 10.1002/wsbm.1422 Liu, 2016, Aberrant regulation of Wnt signaling in hepatocellular carcinoma, World J. Gastroenterol., 22, 7486, 10.3748/wjg.v22.i33.7486 Cao, 2019, miR-122 enhances sensitivity of hepatocellular carcinoma to oxaliplatin via inhibiting MDR1 by targeting Wnt/β-catenin pathway, Exp. Mol. Pathol., 106, 34, 10.1016/j.yexmp.2018.10.009 Lei, 2014, Suppression of MIM by microRNA-182 activates RhoA and promotes breast cancer metastasis, Oncogene, 33, 1287, 10.1038/onc.2013.65 Wang, 2013, MicroRNA-182 promotes cell growth, invasion, and chemoresistance by targeting programmed cell death 4 (PDCD4) in human ovarian carcinomas, J. Cell. Biochem., 114, 1464, 10.1002/jcb.24488 Husted, 2011, MicroRNA expression profiles associated with development of drug resistance in Ehrlich ascites tumor cells, Mol. Pharm., 8, 2055, 10.1021/mp200255d Yang, 2012, Aberrant microRNA-182 expression is associated with glucocorticoid resistance in lymphoblastic malignancies, Leuk. Lymphoma, 53, 2465, 10.3109/10428194.2012.693178 Qin, 2014, Upregulated miR-182 increases drug resistance in cisplatin-treated HCC cell by regulating TP53INP1, Gene, 538, 342, 10.1016/j.gene.2013.12.043 Sümbül, 2014, miR-204-5p expression in colorectal cancer: An autophagy-associated gene, Tumour Biol., 35, 12713, 10.1007/s13277-014-2596-3 Butrym, 2015, Low expression of microRNA-204 (miR-204) is associated with poor clinical outcome of acute myeloid leukemia (AML) patients, J. Exp. Clin. Cancer Res., 34, 68, 10.1186/s13046-015-0184-z Luo, 2017, Promising significance of the association of miR-204-5p expression with clinicopathological features of hepatocellular carcinoma, Medicine (Baltimore), 96, e7545, 10.1097/MD.0000000000007545 Jiang, 2016, miR-204-5p targeting SIRT1 regulates hepatocellular carcinoma progression, Cell Biochem. Funct., 34, 505, 10.1002/cbf.3223 Zeng, 2012, Differential combinatorial regulatory network analysis related to venous metastasis of hepatocellular carcinoma, BMC Genomics, 13, S14, 10.1186/1471-2164-13-S8-S14 Yu, 2019, miR-204 inhibits hepatocellular cancer drug resistance and metastasis through targeting NUAK1, Biochem. Cell Biol., 97, 563, 10.1139/bcb-2018-0354 Zheng, 2017, Alcohol-dysregulated microRNAs in hepatitis B virus-related hepatocellular carcinoma, PLoS ONE, 12, e0178547, 10.1371/journal.pone.0178547 Yang, 2013, miR-223 modulates multidrug resistance via downregulation of ABCB1 in hepatocellular carcinoma cells, Exp. Biol. Med. (Maywood), 238, 1024, 10.1177/1535370213497321 Ji, 2015, Identification of microRNAs specific for epithelial cell adhesion molecule-positive tumor cells in hepatocellular carcinoma, Hepatology, 62, 829, 10.1002/hep.27886 Wong, 2008, MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1, Gastroenterology, 135, 257, 10.1053/j.gastro.2008.04.003 Dong, 2014, Sulfatide epigenetically regulates miR-223 and promotes the migration of human hepatocellular carcinoma cells, J. Hepatol., 60, 792, 10.1016/j.jhep.2013.12.004 Zhou, 2011, Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma, J. Clin. Oncol., 29, 4781, 10.1200/JCO.2011.38.2697 Liu, 2018, MicroRNA-223 protects neonatal rat cardiomyocytes and H9c2 cells from hypoxia-induced apoptosis and excessive autophagy via the Akt/mTOR pathway by targeting PARP-1, J. Mol. Cell. Cardiol., 118, 133, 10.1016/j.yjmcc.2018.03.018 Zhou, 2019, miR-223 overexpression inhibits doxorubicin-induced autophagy by targeting FOXO3a and reverses chemoresistance in hepatocellular carcinoma cells, Cell Death Dis., 10, 843, 10.1038/s41419-019-2053-8 Budhu, 2008, Identification of metastasis-related microRNAs in hepatocellular carcinoma, Hepatology, 47, 897, 10.1002/hep.22160 Ura, 2009, Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma, Hepatology, 49, 1098, 10.1002/hep.22749 Kim, 2013, Sirtuin7 oncogenic potential in human hepatocellular carcinoma and its regulation by the tumor suppressors miR-125a-5p and miR-125b, Hepatology, 57, 1055, 10.1002/hep.26101 Liang, 2010, MicroRNA-125b suppressesed human liver cancer cell proliferation and metastasis by directly targeting oncogene LIN28B2, Hepatology, 52, 1731, 10.1002/hep.23904 Li, 2008, Diagnostic and prognostic implications of microRNAs in human hepatocellular carcinoma, Int. J. Cancer, 123, 1616, 10.1002/ijc.23693 Ren, 2018, MicroRNA-125b reverses oxaliplatin resistance in hepatocellular carcinoma by negatively regulating EVA1A mediated autophagy, Cell Death Dis., 9, 547, 10.1038/s41419-018-0592-z Stinson, 2011, miR-221/222 targeting of trichorhinophalangeal 1 (TRPS1) promotes epithelial-to-mesenchymal transition in breast cancer, Sci. Signal., 4, pt5, 10.1126/scisignal.2001538 Yang, 2011, miR-221 and miR-222 expression increased the growth and tumorigenesis of oral carcinoma cells, J. Oral Pathol. Med., 40, 560, 10.1111/j.1600-0714.2010.01005.x Lu, 2018, Retraction, J. Biol. Chem., 293, 3588, 10.1074/jbc.W118.002430 Miller, 2008, MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1, J. Biol. Chem., 283, 29897, 10.1074/jbc.M804612200 Zhang, 2010, miR-221 and miR-222 target PUMA to induce cell survival in glioblastoma, Mol. Cancer, 9, 229, 10.1186/1476-4598-9-229 Wong, 2010, miR-222 overexpression confers cell migratory advantages in hepatocellular carcinoma through enhancing AKT signaling, Clin. Cancer Res., 16, 867, 10.1158/1078-0432.CCR-09-1840 Zhong, 2013, miR-222 and miR-29a contribute to the drug-resistance of breast cancer cells, Gene, 531, 8, 10.1016/j.gene.2013.08.062 Garofalo, 2009, miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation, Cancer Cell, 16, 498, 10.1016/j.ccr.2009.10.014 Liu, 2014, miR-222 regulates sorafenib resistance and enhance tumorigenicity in hepatocellular carcinoma, Int. J. Oncol., 45, 1537, 10.3892/ijo.2014.2577 He, 2015, Targeting the microRNA-21/AP1 axis by 5-fluorouracil and pirarubicin in human hepatocellular carcinoma, Oncotarget, 6, 2302, 10.18632/oncotarget.2955 Ma, 2015, MicroRNA-133a and microRNA-326 co-contribute to hepatocellular carcinoma 5-fluorouracil and cisplatin sensitivity by directly targeting B-cell lymphoma-extra large, Mol. Med. Rep., 12, 6235, 10.3892/mmr.2015.4134 Zhuang, 2016, Protein phosphatase 2A-B55δ enhances chemotherapy sensitivity of human hepatocellular carcinoma under the regulation of microRNA-133b, J. Exp. Clin. Cancer Res., 35, 67, 10.1186/s13046-016-0341-z Wang, 2015, MicroRNA-215 is upregulated by treatment with adriamycin and leads to the chemoresistance of hepatocellular carcinoma cells and tissues, Mol. Med. Rep., 12, 5274, 10.3892/mmr.2015.4012 Zheng, 2019, Enhanced antiproliferative effect of resveratrol in head and neck squamous cell carcinoma using GE11 peptide conjugated liposome, Int. J. Mol. Med., 43, 1635 Meng, 2017, Downregulation of miR-33a-5p in hepatocellular carcinoma: A possible mechanism for chemotherapy resistance, Med. Sci. Monit., 23, 1295, 10.12659/MSM.902692 Chen, 2018, miR-590-5p suppresses hepatocellular carcinoma chemoresistance by targeting YAP1 expression, EBioMedicine, 35, 142, 10.1016/j.ebiom.2018.08.010 Jin, 2017, miR-26 enhances chemosensitivity and promotes apoptosis of hepatocellular carcinoma cells through inhibiting autophagy, Cell Death Dis., 8, e2540, 10.1038/cddis.2016.461 Zheng, 2019, miR-34a overexpression enhances the inhibitory effect of doxorubicin on HepG2 cells, World J. Gastroenterol., 25, 2752, 10.3748/wjg.v25.i22.2752 Huang, 2018, Inhibition of microRNA-16 facilitates the paclitaxel resistance by targeting IKBKB via NF-κB signaling pathway in hepatocellular carcinoma, Biochem. Biophys. Res. Commun., 503, 1035, 10.1016/j.bbrc.2018.06.113 Wang, 2016, Targeting PCDH20 gene by microRNA-122 confers 5-FU resistance in hepatic carcinoma, Am. J. Cancer Res., 6, 1681 Yuan, 2016, Overexpression of long non-coding RNA-CTD903 inhibits colorectal cancer invasion and migration by repressing Wnt/β-catenin signaling and predicts favorable prognosis, Int. J. Oncol., 48, 2675, 10.3892/ijo.2016.3447 Long, 2018, Maintenance of stemness by miR-589-5p in hepatocellular carcinoma cells promotes chemoresistance via STAT3 signaling, Cancer Lett., 423, 113, 10.1016/j.canlet.2017.11.031 Jiang, 2014, Overexpression of microRNA-125b sensitizes human hepatocellular carcinoma cells to 5-fluorouracil through inhibition of glycolysis by targeting hexokinase II, Mol. Med. Rep., 10, 995, 10.3892/mmr.2014.2271 Xu, 2019, miR-124 sensitizes cisplatin-induced cytotoxicity against CD133+ hepatocellular carcinoma cells by targeting SIRT1/ROS/JNK pathway, Aging (Albany NY), 11, 2551, 10.18632/aging.101876 Ragheb, 2021, MicroR-520c-3p modulates doxorubicin-chemosensitivity in HepG2 cells, Anticancer. Agents Med. Chem., 21, 237, 10.2174/1871520620666200502004817 He, 2016, MicroRNA-101 sensitizes hepatocellular carcinoma cells to doxorubicin-induced apoptosis via targeting Mcl-1, Mol. Med. Rep., 13, 1923, 10.3892/mmr.2015.4727 Shi, 2014, miR-340 reverses cisplatin resistance of hepatocellular carcinoma cell lines by targeting Nrf2-dependent antioxidant pathway, Asian Pac. J. Cancer Prev., 15, 10439, 10.7314/APJCP.2014.15.23.10439 Yin, 2015, miR-193b acts as a cisplatin sensitizer via the caspase-3-dependent pathway in HCC chemotherapy, Oncol. Rep., 34, 368, 10.3892/or.2015.3996 Ou, 2015, Downregulation of miR-363 increases drug resistance in cisplatin-treated HepG2 by dysregulating Mcl-1, Gene, 572, 116, 10.1016/j.gene.2015.07.002 Xu, 2012, Upregulated miR-130a increases drug resistance by regulating RUNX3 and Wnt signaling in cisplatin-treated HCC cell, Biochem. Biophys. Res. Commun., 425, 468, 10.1016/j.bbrc.2012.07.127 Yang, 2019, MicroRNA-3163 targets ADAM-17 and enhances the sensitivity of hepatocellular carcinoma cells to molecular targeted agents, Cell Death Dis., 10, 784, 10.1038/s41419-019-2023-1 Xu, 2016, MicroRNA-122 confers sorafenib resistance to hepatocellular carcinoma cells by targeting IGF-1R to regulate RAS/RAF/ERK signaling pathways, Cancer Lett., 371, 171, 10.1016/j.canlet.2015.11.034 Fornari, 2017, Hepatocellular carcinoma miR-221 modulates sorafenib resistance through inhibition of caspase-3-mediated apoptosis, Clin. Cancer Res., 23, 3953, 10.1158/1078-0432.CCR-16-1464 Lu, 2017, Upregulation of miR-137 reverses sorafenib resistance and cancer-initiating cell phenotypes by degrading ANT2 in hepatocellular carcinoma, Oncol. Rep., 37, 2071, 10.3892/or.2017.5498 Wang, 2013, miR-23a-mediated inhibition of topoisomerase 1 expression potentiates cell response to etoposide in human hepatocellular carcinoma, Mol. Cancer, 12, 119, 10.1186/1476-4598-12-119 Mu, 2015, miR-27b synergizes with anticancer drugs via p53 activation and CYP1B1 suppression, Cell Res., 25, 477, 10.1038/cr.2015.23 Soliman, 2021, miR-372-3p predicts response of TACE patients treated with doxorubicin and enhances chemosensitivity in hepatocellular carcinoma, Anticancer Agents Med. Chem., 21, 246, 10.2174/1871520620666200516145830 Tao, 2012, MicroRNA-133 inhibits cell proliferation, migration and invasion in prostate cancer cells by targeting the epidermal growth factor receptor, Oncol. Rep., 27, 1967 Zhou, 2013, MicroRNA-133 inhibits cell proliferation, migration and invasion by targeting epidermal growth factor receptor and its downstream effector proteins in bladder cancer, Scand. J. Urol., 47, 423, 10.3109/00365599.2012.748821 Liu, 2012, MicroRNA-133b inhibits the growth of non-small-cell lung cancer by targeting the epidermal growth factor receptor, FEBS J., 279, 3800, 10.1111/j.1742-4658.2012.08741.x Qiu, 2014, miR-145, miR-133a and miR-133b inhibit proliferation, migration, invasion and cell cycle progression via targeting transcription factor Sp1 in gastric cancer, FEBS Lett., 588, 1168, 10.1016/j.febslet.2014.02.054 Kano, 2010, miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma, Int. J. Cancer, 127, 2804, 10.1002/ijc.25284 Ceresa, 2014, Cell and molecular biology of epidermal growth factor receptor, Int. Rev. Cell Mol. Biol., 313, 145, 10.1016/B978-0-12-800177-6.00005-0 Centuori, 2014, Differential regulation of EGFR-MAPK signaling by deoxycholic acid (DCA) and ursodeoxycholic acid (UDCA) in colon cancer, Dig. Dis. Sci., 59, 2367, 10.1007/s10620-014-3190-7 Wang, 2014, Retraction, Tumour Biol. Guo, 2016, Assessment of epidermal growth factor receptor mutation/copy number and K-ras mutation in esophageal cancer, J. Thorac. Dis., 8, 1753, 10.21037/jtd.2016.06.17 Song, 2016, Epidermal growth factor receptor and B7-H3 expression in esophageal squamous tissues correlate to patient prognosis, OncoTargets Ther., 9, 6257, 10.2147/OTT.S111691 Kashyap, 2018, Expression, regulation and targeting of receptor tyrosine kinases in esophageal squamous cell carcinoma, Mol. Cancer, 17, 54, 10.1186/s12943-018-0790-4 Pan, 2018, miR-145 suppresses the proliferation, invasion and migration of NSCLC cells by regulating the BAX/BCL-2 ratio and the caspase-3 cascade, Oncol. Lett., 15, 4337 Ye, 2018, miR-145 overexpression triggers alteration of the whole transcriptome and inhibits breast cancer development, Biomed. Pharmacother., 100, 72, 10.1016/j.biopha.2018.01.167 Azmi, 2017, Exportin 1 (XPO1) inhibition leads to restoration of tumor suppressor miR-145 and consequent suppression of pancreatic cancer cell proliferation and migration, Oncotarget, 8, 82144, 10.18632/oncotarget.19285 Wu, 2011, miRNA profile in esophageal squamous cell carcinoma: downregulation of miR-143 and miR-145, World J. Gastroenterol., 17, 79, 10.3748/wjg.v17.i1.79 Mei, 2017, miR-145-5p suppresses tumor cell migration, invasion and epithelial to mesenchymal transition by regulating the Sp1/NF-κB signaling pathway in esophageal squamous cell carcinoma, Int. J. Mol. Sci., 18, 1833, 10.3390/ijms18091833 Cui, 2016, Targeting oncogenic PLCE1 by miR-145 impairs tumor proliferation and metastasis of esophageal squamous cell carcinoma, Oncotarget, 7, 1777, 10.18632/oncotarget.6499 Akao, 2014, Extracellular disposal of tumor-suppressor miRs-145 and -34a via microvesicles and 5-FU resistance of human colon cancer cells, Int. J. Mol. Sci., 15, 1392, 10.3390/ijms15011392 Chen, 2019, miR-145 regulates the sensitivity of esophageal squamous cell carcinoma cells to 5-FU via targeting REV3L, Pathol. Res. Pract., 215, 152427, 10.1016/j.prp.2019.04.019 Liang, 2015, miR-193a-3p functions as a tumor suppressor in lung cancer by down-regulating ERBB4, J. Biol. Chem., 290, 926, 10.1074/jbc.M114.621409 Kwon, 2013, Ionizing radiation-inducible microRNA miR-193a-3p induces apoptosis by directly targeting Mcl-1, Apoptosis, 18, 896, 10.1007/s10495-013-0841-7 Gao, 2011, MicroRNA-193a represses c-kit expression and functions as a methylation-silenced tumor suppressor in acute myeloid leukemia, Oncogene, 30, 3416, 10.1038/onc.2011.62 Meng, 2016, miR-193a-3p regulation of chemoradiation resistance in oesophageal cancer cells via the PSEN1 gene, Gene, 579, 139, 10.1016/j.gene.2015.12.060 Korhan, 2014, miR-181a-5p is downregulated in hepatocellular carcinoma and suppresses motility, invasion and branching-morphogenesis by directly targeting c-Met, Biochem. Biophys. Res. Commun., 450, 1304, 10.1016/j.bbrc.2014.06.142 Liu, 2017, MEG2 is regulated by miR-181a-5p and functions as a tumour suppressor gene to suppress the proliferation and migration of gastric cancer cells, Mol. Cancer, 16, 133, 10.1186/s12943-017-0695-7 Hummel, 2014, MicroRNA signatures in chemotherapy resistant esophageal cancer cell lines, World J. Gastroenterol., 20, 14904, 10.3748/wjg.v20.i40.14904 Yang, 2020, miRNA-181a-5p enhances the sensitivity of cells to cisplatin in esophageal adenocarcinoma by targeting CBLB, Cancer Manag. Res., 12, 4981, 10.2147/CMAR.S251264 Singh, 2014, Exosome-mediated transfer of miR-10b promotes cell invasion in breast cancer, Mol. Cancer, 13, 256, 10.1186/1476-4598-13-256 Liu, 2007, AKT1 amplification regulates cisplatin resistance in human lung cancer cells through the mammalian target of rapamycin/p70S6K1 pathway, Cancer Res., 67, 6325, 10.1158/0008-5472.CAN-06-4261 Huang, 2015, MicroRNA miR-10b inhibition reduces cell proliferation and promotes apoptosis in non-small cell lung cancer (NSCLC) cells, Mol. Biosyst., 11, 2051, 10.1039/C4MB00752B Guan, 2018, Up-regulation of miR-10b-3p promotes the progression of hepatocellular carcinoma cells via targeting CMTM5, J. Cell. Mol. Med., 22, 3434, 10.1111/jcmm.13620 Nishida, 2012, MicroRNA-10b is a prognostic indicator in colorectal cancer and confers resistance to the chemotherapeutic agent 5-fluorouracil in colorectal cancer cells, Ann. Surg. Oncol., 19, 3065, 10.1245/s10434-012-2246-1 Zhang, 2016, MicroRNA-10b regulates epithelial-mesenchymal transition by modulating KLF4/Notch1/E-cadherin in cisplatin-resistant nasopharyngeal carcinoma cells, Am. J. Cancer Res., 6, 141 Ahmad, 2015, Functional role of miR-10b in tamoxifen resistance of ER-positive breast cancer cells through down-regulation of HDAC4, BMC Cancer, 15, 540, 10.1186/s12885-015-1561-x Tian, 2010, MicroRNA-10b promotes migration and invasion through KLF4 in human esophageal cancer cell lines, J. Biol. Chem., 285, 7986, 10.1074/jbc.M109.062877 Wu, 2020, MicroRNA-10b confers cisplatin resistance by activating AKT/mTOR/P70S6K signaling via targeting PPARγ in esophageal cancer, J. Cell. Physiol., 235, 1247, 10.1002/jcp.29040 Guo, 2014, miR-96 downregulates RECK to promote growth and motility of non-small cell lung cancer cells, Mol. Cell. Biochem., 390, 155, 10.1007/s11010-014-1966-x Lin, 2010, Unregulated miR-96 induces cell proliferation in human breast cancer by downregulating transcriptional factor FOXO3a, PLoS ONE, 5, e15797, 10.1371/journal.pone.0015797 Fendler, 2013, The antiapoptotic function of miR-96 in prostate cancer by inhibition of FOXO1, PLoS ONE, 8, e80807, 10.1371/journal.pone.0080807 Guo, 2012, miR-96 regulates FOXO1-mediated cell apoptosis in bladder cancer, Oncol. Lett., 4, 561, 10.3892/ol.2012.775 Zhang, 2014, miR-96 promotes tumor proliferation and invasion by targeting RECK in breast cancer, Oncol. Rep., 31, 1357, 10.3892/or.2013.2934 Eichelmann, 2018, Complex role of miR-130a-3p and miR-148a-3p balance on drug resistance and tumor biology in esophageal squamous cell carcinoma, Sci. Rep., 8, 17553, 10.1038/s41598-018-35799-1 Yang, 2019, Influence of exosome-derived miR-21on chemotherapy resistance of esophageal cancer, Eur. Rev. Med. Pharmacol. Sci., 23, 1513 Hu, 2019, lncRNA CCAT1 is a biomarker for the proliferation and drug resistance of esophageal cancer via the miR-143/PLK1/BUBR1 axis, Mol. Carcinog., 58, 2207, 10.1002/mc.23109 Huang, 2019, Disruption of cancer metabolic SREBP1/miR-142-5p suppresses epithelial-mesenchymal transition and stemness in esophageal carcinoma, Cells, 9, 7, 10.3390/cells9010007 Jin, 2016, Involvement of microRNA-141-3p in 5-fluorouracil and oxaliplatin chemo-resistance in esophageal cancer cells via regulation of PTEN, Mol. Cell. Biochem., 422, 161, 10.1007/s11010-016-2816-9 Chang, 2018, lncRNA-TUSC7/miR-224 affected chemotherapy resistance of esophageal squamous cell carcinoma by competitively regulating DESC1, J. Exp. Clin. Cancer Res., 37, 56, 10.1186/s13046-018-0724-4 Tanaka, 2015, miR-27 is associated with chemoresistance in esophageal cancer through transformation of normal fibroblasts to cancer-associated fibroblasts, Carcinogenesis, 36, 894, 10.1093/carcin/bgv067 Ma, 2016, Inhibition of miR-196a affects esophageal cancer cell growth in vitro, Biomed. Pharmacother., 84, 22, 10.1016/j.biopha.2016.09.013 Hummel, 2011, Mir-148a improves response to chemotherapy in sensitive and resistant oesophageal adenocarcinoma and squamous cell carcinoma cells, J. Gastrointest. Surg., 15, 429, 10.1007/s11605-011-1418-9 Sugimura, 2012, Let-7 expression is a significant determinant of response to chemotherapy through the regulation of IL-6/STAT3 pathway in esophageal squamous cell carcinoma, Clin. Cancer Res., 18, 5144, 10.1158/1078-0432.CCR-12-0701 Akdemir, 2017, miR-432 induces NRF2 stabilization by directly targeting KEAP1, Mol. Cancer Res., 15, 1570, 10.1158/1541-7786.MCR-17-0232 Wang, 2015, miR-499 enhances the cisplatin sensitivity of esophageal carcinoma cell lines by targeting DNA polymerase β, Cell. Physiol. Biochem., 36, 1587, 10.1159/000430321 Hamano, 2011, Overexpression of miR-200c induces chemoresistance in esophageal cancers mediated through activation of the Akt signaling pathway, Clin. Cancer Res., 17, 3029, 10.1158/1078-0432.CCR-10-2532 Komatsu, 2016, Circulating miR-21 as an independent predictive biomarker for chemoresistance in esophageal squamous cell carcinoma, Am. J. Cancer Res., 6, 1511 Ma, 2016, miR-483-3p plays an oncogenic role in esophageal squamous cell carcinoma by targeting tumor suppressor EI24, Cell Biol. Int., 40, 448, 10.1002/cbin.10585 Imanaka, 2011, MicroRNA-141 confers resistance to cisplatin-induced apoptosis by targeting YAP1 in human esophageal squamous cell carcinoma, J. Hum. Genet., 56, 270, 10.1038/jhg.2011.1 Li, 2019, Identification of miR-29c and its target FBXO31 as a Key regulatory mechanism in esophageal cancer chemoresistance: Functional validation and clinical significance, Theranostics, 9, 1599, 10.7150/thno.30372 Chen, 2017, Long non-coding RNAs in anti-cancer drug resistance, Oncotarget, 8, 1925, 10.18632/oncotarget.12461 Wang, 2017, Long noncoding RNA UCA1 induced by SP1 promotes cell proliferation via recruiting EZH2 and activating AKT pathway in gastric cancer, Cell Death Dis., 8, e2839, 10.1038/cddis.2017.143 Wang, 2017, Long noncoding RNA UCA1 promotes tumour metastasis by inducing GRK2 degradation in gastric cancer, Cancer Lett., 408, 10, 10.1016/j.canlet.2017.08.013 He, 2019, lncRNA UCA1 predicts a poor prognosis and regulates cell proliferation and migration by repressing p21 and SPRY1 expression in GC, Mol. Ther. Nucleic Acids, 18, 605, 10.1016/j.omtn.2019.09.024 Xie, 2019, circEPSTI1 regulates ovarian cancer progression via decoying miR-942, J. Cell. Mol. Med., 23, 3597, 10.1111/jcmm.14260 Li, 2020, Deregulation of UCA1 expression may be involved in the development of chemoresistance to cisplatin in the treatment of non-small-cell lung cancer via regulating the signaling pathway of microRNA-495/NRF2, J. Cell. Physiol., 235, 3721, 10.1002/jcp.29266 Fang, 2017, lncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression, Cancer Med., 6, 2897, 10.1002/cam4.1253 Pan, 2016, Long non-coding RNA UCA1 promotes cisplatin/gemcitabine resistance through CREB modulating miR-196a-5p in bladder cancer cells, Cancer Lett., 382, 64, 10.1016/j.canlet.2016.08.015 Fang, 2016, Long non-coding RNA (lncRNA) urothelial carcinoma associated 1 (UCA1) increases multi-drug resistance of gastric cancer via downregulating miR-27b, Med. Sci. Monit., 22, 3506, 10.12659/MSM.900688 Qin, 2021, Retraction, J. Cell. Biochem., 122, 722 Elmore, 2007, Apoptosis: A review of programmed cell death, Toxicol. Pathol., 35, 495, 10.1080/01926230701320337 Ye, 2019, HOXD-AS1 confers cisplatin resistance in gastric cancer through epigenetically silencing PDCD4 via recruiting EZH2, Open Biol., 9, 190068, 10.1098/rsob.190068 Sun, 2018, Enhancer of zeste homolog 2 promotes cisplatin resistance by reducing cellular platinum accumulation, Cancer Sci., 109, 1853, 10.1111/cas.13599 Liu, 2019, LINC00665 induces acquired resistance to gefitinib through recruiting EZH2 and activating PI3K/AKT pathway in NSCLC, Mol. Ther. Nucleic Acids, 16, 155, 10.1016/j.omtn.2019.02.010 Zhang, 2019, LINC01210 accelerates proliferation, invasion and migration in ovarian cancer through epigenetically downregulating KLF4, Biomed. Pharmacother., 119, 109431, 10.1016/j.biopha.2019.109431 Xi, 2016, Retraction, Oncogene, 35, 5576, 10.1038/onc.2016.64 Zhao, 2018, Long noncoding RNA FEZF1-AS1 promotes proliferation and inhibits apoptosis in ovarian cancer by activation of JAK-STAT3 pathway, Med. Sci. Monit., 24, 8088, 10.12659/MSM.911194 Dai, 2020, lncRNA UCA1 promotes cisplatin resistance in gastric cancer via recruiting EZH2 and activating PI3K/AKT pathway, J. Cancer, 11, 3882, 10.7150/jca.43446 Yang, 2019, FAM83H-AS1 is upregulated and predicts poor prognosis in colon cancer, Biomed. Pharmacother., 118, 109342, 10.1016/j.biopha.2019.109342 Barr, 2019, Long non-coding RNA FAM83H-AS1 is regulated by human papillomavirus 16 E6 independently of p53 in cervical cancer cells, Sci. Rep., 9, 3662, 10.1038/s41598-019-40094-8 Yang, 2016, Identification of lncRNA FAM83H-AS1 as a novel prognostic marker in luminal subtype breast cancer, OncoTargets Ther., 9, 7039, 10.2147/OTT.S110055 Da, 2019, Upregulation of the long non-coding RNA FAM83H-AS1 in gastric cancer and its clinical significance, Pathol. Res. Pract., 215, 152616, 10.1016/j.prp.2019.152616 Wang, 2020, Silence of FAM83H-AS1 promotes chemosensitivity of gastric cancer through Wnt/β-catenin signaling pathway, Biomed. Pharmacother., 125, 109961, 10.1016/j.biopha.2020.109961 Yoon, 2014, Functional interactions among microRNAs and long noncoding RNAs, Semin. Cell Dev. Biol., 34, 9, 10.1016/j.semcdb.2014.05.015 Cheng, 2018, Knockdown of long non-coding RNA HOTAIR inhibits cisplatin resistance of gastric cancer cells through inhibiting the PI3K/Akt and Wnt/β-catenin signaling pathways by up-regulating miR-34a, Int. J. Biol. Macromol., 107, 2620, 10.1016/j.ijbiomac.2017.10.154 Zhou, 2018, The long noncoding RNA D63785 regulates chemotherapy sensitivity in human gastric cancer by targeting miR-422a, Mol. Ther. Nucleic Acids, 12, 405, 10.1016/j.omtn.2018.05.024 Zeng, 2018, Long non-coding RNA XLOC_006753 promotes the development of multidrug resistance in gastric cancer cells through the PI3K/AKT/mTOR signaling pathway, Cell. Physiol. Biochem., 51, 1221, 10.1159/000495499 Zhang, 2015, Overexpression of long non-coding RNA PVT1 in gastric cancer cells promotes the development of multidrug resistance, Biochem. Biophys. Res. Commun., 462, 227, 10.1016/j.bbrc.2015.04.121 Sun, 2020, Long non-coding RNA SNHG3, induced by IL-6/STAT3 transactivation, promotes stem cell-like properties of gastric cancer cells by regulating the miR-3619-5p/ARL2 axis, Cell. Oncol. (Dordr.), 44, 179, 10.1007/s13402-020-00560-2 Shi, 2019, Long non-coding RNA LINC00346 promotes pancreatic cancer growth and gemcitabine resistance by sponging miR-188-3p to derepress BRD4 expression, J. Exp. Clin. Cancer Res., 38, 60, 10.1186/s13046-019-1055-9 Ye, 2017, Long noncoding RNA linc00346 promotes the malignant phenotypes of bladder cancer, Biochem. Biophys. Res. Commun., 491, 79, 10.1016/j.bbrc.2017.07.045 Zhang, 2018, Long non-coding RNA LINC00346, LINC00578, LINC00673, LINC00671, LINC00261, and SNHG9 are novel prognostic markers for pancreatic cancer, Am. J. Transl. Res., 10, 2648 Hua, 2019, Long non-coding SBF2-AS1 acting as a competing endogenous RNA to sponge microRNA-142-3p to participate in gemcitabine resistance in pancreatic cancer via upregulating TWF1, Aging (Albany NY), 11, 8860, 10.18632/aging.102307 Coccia, 1992, Regulation and expression of a growth arrest-specific gene (gas5) during growth, differentiation, and development, Mol. Cell. Biol., 12, 3514 DiStefano, 2018, The emerging role of long noncoding RNAs in human disease, Methods Mol. Biol., 1706, 91, 10.1007/978-1-4939-7471-9_6 Prensner, 2011, The emergence of lncRNAs in cancer biology, Cancer Discov., 1, 391, 10.1158/2159-8290.CD-11-0209 Gao, 2017, Prognostic values of long noncoding RNA GAS5 in various carcinomas: An updated systematic review and meta-analysis, Front. Physiol., 8, 814, 10.3389/fphys.2017.00814 Pickard, 2015, Molecular and cellular mechanisms of action of tumour suppressor GAS5 lncRNA, Genes (Basel), 6, 484, 10.3390/genes6030484 Wang, 2020, Downregulation of lncRNA GAS5 promotes liver cancer proliferation and drug resistance by decreasing PTEN expression, Mol. Genet. Genomics, 295, 251, 10.1007/s00438-019-01620-5 Wang, 2017, Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis, Mol. Cancer, 16, 123, 10.1186/s12943-017-0702-z Baldinu, 2007, CASC2a gene is down-regulated in endometrial cancer, Anticancer Res., 27, 235 Gao, 2019, Long non-coding RNA CASC2 regulates Sprouty2 via functioning as a competing endogenous RNA for miR-183 to modulate the sensitivity of prostate cancer cells to docetaxel, Arch. Biochem. Biophys., 665, 69, 10.1016/j.abb.2018.01.013 Ambros, 2001, MicroRNAs: Tiny regulators with great potential, Cell, 107, 823, 10.1016/S0092-8674(01)00616-X Wang, 2014, CARL lncRNA inhibits anoxia-induced mitochondrial fission and apoptosis in cardiomyocytes by impairing miR-539-dependent PHB2 downregulation, Nat. Commun., 5, 3596, 10.1038/ncomms4596 Feng, 2017, Modulation of CASC2/miR-21/PTEN pathway sensitizes cervical cancer to cisplatin, Arch. Biochem. Biophys., 623–624, 20, 10.1016/j.abb.2017.05.001 Jiang, 2018, Upregulation of CASC2 sensitized glioma to temozolomide cytotoxicity through autophagy inhibition by sponging miR-193a-5p and regulating mTOR expression, Biomed. Pharmacother., 97, 844, 10.1016/j.biopha.2017.10.146 Wang, 2018, LINC00473 promotes the Taxol resistance via miR-15a in colorectal cancer, Biosci. Rep., 38 Yu, 2019, Exosomes derived from microRNA-199a-overexpressing mesenchymal stem cells inhibit glioma progression by down-regulating AGAP2, Aging (Albany NY), 11, 5300, 10.18632/aging.102092 Liang, 2010, The novel human endogenous retrovirus-related gene, psiTPTE22-HERV, is silenced by DNA methylation in cancers, Int. J. Cancer, 127, 1833, 10.1002/ijc.25213 Choi, 2017, Alteration of DNA methylation in gastric cancer with chemotherapy, J. Microbiol. Biotechnol., 27, 1367, 10.4014/jmb.1704.04035 Vera, 2017, DNA methylation of miR-7 is a mechanism involved in platinum response through MAFG overexpression in cancer cells, Theranostics, 7, 4118, 10.7150/thno.20112 van Jaarsveld, 2013, miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells, Oncogene, 32, 4284, 10.1038/onc.2012.433 Ding, 2019, Long non-coding RNA TPTEP1 inhibits hepatocellular carcinoma progression by suppressing STAT3 phosphorylation, J. Exp. Clin. Cancer Res., 38, 189, 10.1186/s13046-019-1193-0 Huang, 2018, lncRNA NR2F1-AS1 regulates hepatocellular carcinoma oxaliplatin resistance by targeting ABCC1 via miR-363, J. Cell. Mol. Med., 22, 3238, 10.1111/jcmm.13605 Xu, 2020, Long non-coding RNAs as targets for immunosuppressive drug teriflunomide in anti-cancer potential for hepatocellular carcinoma, J. Mol. Histol., 51, 659, 10.1007/s10735-020-09912-6 Sun, 2018, Long non-coding RNA 00607 as a tumor suppressor by modulating NF-κB p65/p53 signaling axis in hepatocellular carcinoma, Carcinogenesis, 39, 1438, 10.1093/carcin/bgy113 Hu, 2018, Long non-coding RNA KCNQ1OT1 modulates oxaliplatin resistance in hepatocellular carcinoma through miR-7-5p/ ABCC1 axis, Biochem. Biophys. Res. Commun., 503, 2400, 10.1016/j.bbrc.2018.06.168 Jin, 2017, Long non-coding RNA TUC338 is functionally involved in sorafenib-sensitized hepatocarcinoma cells by targeting RASAL1, Oncol. Rep., 37, 273, 10.3892/or.2016.5248 Sui, 2019, lncRNA FOXD2-AS1 as a competitive endogenous RNA against miR-150-5p reverses resistance to sorafenib in hepatocellular carcinoma, J. Cell. Mol. Med., 23, 6024, 10.1111/jcmm.14465 Liu, 2019, miR-96-5p promotes the proliferation and migration of ovarian cancer cells by suppressing Caveolae1, J. Ovarian Res., 12, 57, 10.1186/s13048-019-0533-1 Hu, 2015, BCYRN1, a c-MYC-activated long non-coding RNA, regulates cell metastasis of non-small-cell lung cancer, Cancer Cell Int., 15, 36, 10.1186/s12935-015-0183-3 Booy, 2017, The long non-coding RNA BC200 (BCYRN1) is critical for cancer cell survival and proliferation, Mol. Cancer, 16, 109, 10.1186/s12943-017-0679-7 Ding, 2020, lncRNA BCYRN1/miR-490-3p/POU3F2, served as a ceRNA network, is connected with worse survival rate of hepatocellular carcinoma patients and promotes tumor cell growth and metastasis, Cancer Cell Int., 20, 6, 10.1186/s12935-019-1081-x Zhai, 2019, BCYRN1 is correlated with progression and prognosis in gastric cancer, Biosci. Rep., 39, 10.1042/BSR20190505 Wang, 2018, Brain cytoplasmic RNA 1 suppresses smooth muscle differentiation and vascular development in mice, J. Biol. Chem., 293, 5668, 10.1074/jbc.RA117.001578 Zhang, 2017, Schisandrin B down-regulated lncRNA BCYRN1 expression of airway smooth muscle cells by improving miR-150 expression to inhibit the proliferation and migration of ASMC in asthmatic rats, Cell Prolif., 50, e12382, 10.1111/cpr.12382 Yang, 2020, Long non-coding RNA BCYRN1 exerts an oncogenic role in colorectal cancer by regulating the miR-204-3p/KRAS axis, Cancer Cell Int., 20, 453, 10.1186/s12935-020-01543-x Young, 2005, The noncoding RNA taurine upregulated gene 1 is required for differentiation of the murine retina, Curr. Biol., 15, 501, 10.1016/j.cub.2005.02.027 Tan, 2015, Double-negative feedback loop between long non-coding RNA TUG1 and miR-145 promotes epithelial to mesenchymal transition and radioresistance in human bladder cancer cells, FEBS Lett., 589, 3175, 10.1016/j.febslet.2015.08.020 Zhang, 2016, Increased expression of long noncoding RNA TUG1 predicts a poor prognosis of gastric cancer and regulates cell proliferation by epigenetically silencing of p57, Cell Death Dis., 7, e2109, 10.1038/cddis.2015.356 Zhu, 2017, Long non-coding RNA TUG1 promotes cervical cancer progression by regulating the miR-138-5p-SIRT1 axis, Oncotarget, 8, 65253, 10.18632/oncotarget.18224 Zhang, 2014, p53-regulated long non-coding RNA TUG1 affects cell proliferation in human non-small cell lung cancer, partly through epigenetically regulating HOXB7 expression, Cell Death Dis., 5, e1243, 10.1038/cddis.2014.201 Li, 2017, TUG1 mediates methotrexate resistance in colorectal cancer via miR-186/CPEB2 axis, Biochem. Biophys. Res. Commun., 491, 552, 10.1016/j.bbrc.2017.03.042 Wang, 2019, Long non-coding RNA TUG1 mediates 5-fluorouracil resistance by acting as a ceRNA of miR-197-3p in colorectal cancer, J. Cancer, 10, 4603, 10.7150/jca.32065 Wu, 2019, Long non-coding RNA PCAT6 targets miR-204 to modulate the chemoresistance of colorectal cancer cells to 5-fluorouracil-based treatment through HMGA2 signaling, Cancer Med., 8, 2484, 10.1002/cam4.1809 Doherty, 2011, The endocytic protein GRAF1 is directed to cell-matrix adhesion sites and regulates cell spreading, Mol. Biol. Cell, 22, 4380, 10.1091/mbc.e10-12-0936 Xie, 2018, Downregulated expression of hsa_circ_0074362 in gastric cancer and its potential diagnostic values, Biomarkers Med., 12, 11, 10.2217/bmm-2017-0114 Shao, 2017, Global circular RNA expression profile of human gastric cancer and its clinical significance, Cancer Med., 6, 1173, 10.1002/cam4.1055 Wangxia, 2019, Circular RNA ARHGAP26 is over-expressed and its downregulation inhibits cell proliferation and promotes cell apoptosis in gastric cancer cells, Saudi J. Gastroenterol., 25, 119, 10.4103/sjg.SJG_283_18 Hansen, 2013, Natural RNA circles function as efficient microRNA sponges, Nature, 495, 384, 10.1038/nature11993 Tay, 2014, The multilayered complexity of ceRNA crosstalk and competition, Nature, 505, 344, 10.1038/nature12986 Barrett, 2016, Circular RNAs: Analysis, expression and potential functions, Development, 143, 1838, 10.1242/dev.128074 Memczak, 2013, Circular RNAs are a large class of animal RNAs with regulatory potency, Nature, 495, 333, 10.1038/nature11928 Kulcheski, 2016, Circular RNAs are miRNA sponges and can be used as a new class of biomarker, J. Biotechnol., 238, 42, 10.1016/j.jbiotec.2016.09.011 He, 2019, Overexpressed circPVT1 in oral squamous cell carcinoma promotes proliferation by serving as a miRNA sponge, Mol. Med. Rep., 20, 3509 Li, 2018, Circular RNA circPVT1 promotes proliferation and invasion through sponging miR-125b and activating E2F2 signaling in non-small cell lung cancer, Cell. Physiol. Biochem., 51, 2324, 10.1159/000495876 Chen, 2017, Circular RNA profile identifies circPVT1 as a proliferative factor and prognostic marker in gastric cancer, Cancer Lett., 388, 208, 10.1016/j.canlet.2016.12.006 Kun-Peng, 2018, Overexpressed circPVT1, a potential new circular RNA biomarker, contributes to doxorubicin and cisplatin resistance of osteosarcoma cells by regulating ABCB1, Int. J. Biol. Sci., 14, 321, 10.7150/ijbs.24360 Chen, 2020, Circular RNA_LARP4 sponges miR-1323 and hampers progression of esophageal squamous cell carcinoma through modulating PTEN/PI3K/AKT pathway, Dig. Dis. Sci., 65, 2272, 10.1007/s10620-019-05973-0 Sun, 2020, Circular RNA MCTP2 inhibits cisplatin resistance in gastric cancer by miR-99a-5p-mediated induction of MTMR3 expression, J. Exp. Clin. Cancer Res., 39, 246, 10.1186/s13046-020-01758-w Pan, 2018, Overexpression of circular RNA ciRS-7 abrogates the tumor suppressive effect of miR-7 on gastric cancer via PTEN/PI3K/AKT signaling pathway, J. Cell. Biochem., 119, 440, 10.1002/jcb.26201 Huang, 2020, A novel circular RNA circFN1 enhances cisplatin resistance in gastric cancer via sponging miR-182-5p, J. Cell. Biochem., 122, 1009, 10.1002/jcb.29641 Li, 2020, Circular RNA circFBXO11 modulates hepatocellular carcinoma progress and oxaliplatin resistance through miR-605/FOXO3/ABCB1 axis, J. Cell. Mol. Med., 24, 5152, 10.1111/jcmm.15162 Liu, 2020, circHIPK3 promotes gemcitabine (GEM) resistance in pancreatic cancer cells by sponging miR-330-5p and targets RASSF1, Cancer Manag. Res., 12, 921, 10.2147/CMAR.S239326 Li, 2020, Down-regulation of circ_0032833 sensitizes colorectal cancer to 5-fluorouracil and oxaliplatin partly depending on the regulation of miR-125-5p and MSI1, Cancer Manag. Res., 12, 11257, 10.2147/CMAR.S270123 Jian, 2020, hsa_circ_001680 affects the proliferation and migration of CRC and mediates its chemoresistance by regulating BMI1 through miR-340, Mol. Cancer, 19, 20, 10.1186/s12943-020-1134-8 Wang, 2020, Exosome-delivered circRNA promotes glycolysis to induce chemoresistance through the miR-122-PKM2 axis in colorectal cancer, Mol. Oncol., 14, 539, 10.1002/1878-0261.12629 Amodio, 2018, MALAT1: A druggable long non-coding RNA for targeted anti-cancer approaches, J. Hematol. Oncol., 11, 63, 10.1186/s13045-018-0606-4 Arun, 2016, Differentiation of mammary tumors and reduction in metastasis upon Malat1 lncRNA loss, Genes Dev., 30, 34, 10.1101/gad.270959.115 Liu, 2019, Quercetin-modified gold-palladium nanoparticles as a potential autophagy inducer for the treatment of Alzheimer’s disease, J. Colloid Interface Sci., 552, 388, 10.1016/j.jcis.2019.05.066 Taieb, 2014, Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): An open-label, randomised phase 3 trial, Lancet Oncol., 15, 862, 10.1016/S1470-2045(14)70227-X Arunkumar, 2018, Dysregulation of miR-200 family microRNAs and epithelial-mesenchymal transition markers in oral squamous cell carcinoma, Oncol. Lett., 15, 649 Lin, 2017, Berberine-targeted miR-21 chemosensitizes oral carcinomas stem cells, Oncotarget, 8, 80900, 10.18632/oncotarget.20723 Gong, 2019, Antisense oligonucleotide-conjugated nanostructure-targeting lncRNA MALAT1 inhibits cancer metastasis, ACS Appl. Mater. Interfaces, 11, 37, 10.1021/acsami.8b18288 Di, 2017, The long non-coding RNA HOTAIR promotes thyroid cancer cell growth, invasion and migration through the miR-1-CCND2 axis, Am. J. Cancer Res., 7, 1298